Drug Side Effects
Search
HISTOPLASMOSIS CUTANEOUS
HISTOPLASMOSIS CUTANEOUS
was reported 48 times
HISTOPLASMOSIS CUTANEOUS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Chemokine Receptor Type 4 Interaction [EPC]
1
0.0007
1
Antimetabolite Immunosuppressant [EPC]
10
0.0005
2
Lipid-based Polyene Antifungal [EPC]
4
0.0003
3
Peroxisome Proliferator Receptor alpha Agonist [EPC]
10
0.0002
4
Polyene Antifungal [EPC]
4
0.0001
5
Antirheumatic Agent [EPC]
9
0.0001
6
Human Immunoglobulin G [EPC]
1
0.0000
7
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
8
Interleukin-6 Receptor Antagonist [EPC]
5
0.0000
9
Interleukin-17A Antagonist [EPC]
1
0.0000
10
Corticosteroid [EPC]
34
0.0000
11
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
2
0.0000
12
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
13
Azole Antifungal [EPC]
3
0.0000
14
Tumor Necrosis Factor Blocker [EPC]
12
0.0000
15
gamma-Aminobutyric Acid-ergic Agonist [EPC]
1
0.0000
16
Purine Antimetabolite [EPC]
1
0.0000
17
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
18
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
19
Estrogen [EPC]
1
0.0000
20
Thiazide Diuretic [EPC]
1
0.0000
21
Vitamin D [EPC]
1
0.0000
22
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
23
Vitamin B12 [EPC]
1
0.0000
24
Benzodiazepine [EPC]
2
0.0000
25
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
26
Vitamin C [EPC]
1
0.0000
27
Thalidomide Analog [EPC]
1
0.0000
28
Platelet Aggregation Inhibitor [EPC]
1
0.0000
29
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000